XRN Chiron Real Estate Inc.

CIK 0001533615 50 ready 8-Ks latest August 17, 2026, 4:51 PM ET RSS · JSON

Activity: NORMAL 3 filings / 30d vs 2 baseline Risk accumulating: repeated leadership change (4)

Ready 8-Ks 50

Latest filing August 17, 2026, 4:51 PM ET

Top materiality 0.90

Event mix earnings ×15 · other_material ×14 · leadership ×8

Sentiment 9 pos · 7 neg · 34 neu

Latest earnings reported 2025-FY

Executive change recent →

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for XRN

Highest-materiality recent filing

Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%

May 6, 2026, 7:59 PM ET M&A materiality 0.90 positive item 1.01 item 2.02 item 7.01 item 8.01 item 9.01 ◈ Material Agreements ×3◈ Earnings Releases

Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
Secured $100M convertible preferred equity from Maewyn Capital Partners at 6.00%, initial conversion $43/share.

Read filing →

August 17, 2026, 4:51 PM ET M&A materiality 0.80 positive item 2.01 item 8.01 item 9.01

Chiron completes $248.9M acquisition of two Alexandria senior housing communities

The Landing Alexandria acquired for $130M; The Riviera Alexandria for $118.9M, both in Alexandria, VA.
August 5, 2026, 5:10 PM ET earnings materiality 0.80 positive item 2.02 item 7.01 item 9.01

Chiron Real Estate Q2 net income $63.3M ($4.78/diluted); acquires $249M SHOP communities

Q2 net income $63.3M ($4.78/diluted) vs prior-year net loss $0.8M; Core FFO $1.04/unit vs $1.14.
August 3, 2026, 4:36 PM ET leadership materiality 0.60 neutral item 5.02 item 9.01

Chiron Real Estate appoints Matthew Whitlock as CIO; Alfonzo Leon transitions to Strategic Advisor

Matthew Whitlock appointed Chief Investment Officer effective Aug 3, 2026; base salary $400,000, target bonus 100%.
July 6, 2026, 4:30 PM ET other material materiality 0.70 positive item 7.01 item 9.01

Chiron Real Estate acquires SHOP assets for $249M, forms IRF JV for ~$200M, pending Pinnacle acquisition

Acquired The Riviera and The Landing SHOP communities in June 2026 for $249M total; Riviera 23% occupied, Landing 93% occupied.
July 2, 2026, 5:26 PM ET M&A materiality 0.75 neutral item 1.01 item 2.01 item 9.01

Chiron Real Estate sells seven rehab hospitals for $217M, retains 15% JV interest

Sold seven inpatient rehabilitation hospitals in PA, AZ, TX, NV, OK for $217M; closed June 29, 2026.
June 2, 2026, 4:30 PM ET M&A materiality 0.85 positive item 1.01 item 2.01 item 2.03 item 3.02 item 3.03 item 5.03 item 9.01 ◈ Equity Issuances ×2◈ M&A Transactions ×2◈ Debt Financings◈ Governance Changes◈ Material Agreements

Chiron Real Estate closes $249M acquisition of two senior housing communities; issues $100M Series C preferred

Acquired The Landing Alexandria ($130M) and The Riviera Alexandria ($118.9M) on June 1, 2026.
May 8, 2026, 7:59 PM ET other material materiality 0.75 neutral item 1.01 item 3.02 item 9.01 ◈ Material Agreements ×2◈ Equity Issuances

Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP

Company enters $100M preferred equity purchase agreement with Maewyn XRN LP; initial closing of at least $25M by June 20, 2026.
May 6, 2026, 7:59 PM ET M&A materiality 0.90 positive item 1.01 item 2.02 item 7.01 item 8.01 item 9.01 ◈ Material Agreements ×3◈ Earnings Releases

Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%

Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
February 25, 2026, 6:59 PM ET earnings materiality 0.70 neutral item 2.02 item 5.03 item 7.01 item 8.01 item 9.01 ◈ Governance Changes

Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend

Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
November 18, 2025, 6:59 PM ET debt materiality 0.60 neutral item 1.01 item 3.03 item 5.03 item 9.01 ◈ Equity Issuances◈ Governance Changes

Global Medical REIT to issue 2M shares of 8.00% Series B Preferred Stock at $25/share

Offering of 2,000,000 shares (plus 300,000 over-allotment) of 8.00% Series B cumulative redeemable preferred stock at $25.00 per share.
November 13, 2025, 6:59 PM ET earnings materiality 0.75 negative item 8.01

Global Medical REIT Q3 2025 net loss of $6.0M vs income $1.8M YoY; occupancy 95.2%

Net loss $6.0M ($0.45/diluted share) vs net income $1.8M ($0.14) in Q3 2024.
November 4, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

Global Medical REIT Q3 net loss $6.0M vs income $1.8M; FFO/AFFO up 4%; narrows 2025 AFFO guidance

Net loss $6.0M ($0.45/diluted) vs net income $1.8M ($0.14); includes $6.3M impairment on sold Aurora, IL property.
October 8, 2025, 7:59 PM ET debt materiality 0.65 positive item 1.01 item 2.03 item 7.01 item 9.01

Global Medical REIT amends credit facility, extends maturities to 2029-2031, enters $350M hedges

$400M revolver maturity extended to Oct 2029 with two six-month extension options to Oct 2030.
August 5, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

Global Medical REIT Q2 net loss narrows to $0.8M; appoints Mark Decker Jr. CEO; reaffirms AFFO guidance

Net loss narrowed to $0.8M ($0.01/diluted share) from $3.1M loss YoY; FFO $0.20/share, AFFO $0.23/share.
June 23, 2025, 7:59 PM ET leadership materiality 0.70 positive item 5.02 item 7.01 item 9.01 ◈ executive_change ×3

GMRE appoints Mark Decker as CEO; Jeffrey Busch becomes non-executive Chairman

Mark O. Decker, Jr. appointed CEO and President effective June 23, 2025; also joins Board.
May 28, 2025, 7:59 PM ET dividend materiality 0.75 negative item 7.01 item 8.01 item 9.01

Global Medical REIT cuts quarterly common dividend from $0.21 to $0.15 per share

Board declared Q2 2025 common dividend of $0.15/share, down from $0.21; payable July 9 to holders of record June 20.
May 7, 2025, 7:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q1 net income $2.1M ($0.03/diluted); AFFO $0.22/unit; reaffirms FY2025 AFFO guidance

Net income $2.1M ($0.03/diluted) vs $0.8M ($0.01) prior year; AFFO $0.22/unit vs $0.23.
February 27, 2025, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q4 AFFO $0.22/unit flat YoY; JV with Heitman; 2025 guidance $0.89-$0.93

Q4 2024 net income $1.4M ($0.02/diluted) vs net loss $0.8M (-$0.01) in Q4 2023; full-year net income $0.8M ($0.01) vs $14.8M ($0.23).
January 8, 2025, 6:59 PM ET leadership materiality 0.60 neutral item 5.02 item 7.01 item 8.01 item 9.01

CEO Jeff Busch to step down by June 30, 2025; will remain as non-executive chairman

CEO Jeffrey Busch to leave by earlier of successor appointment or June 30, 2025; to continue as non-executive chairman.
November 6, 2024, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q3 net income $1.8M ($0.03/diluted), FFO $0.19/unit, AFFO $0.22/unit

Rental revenue $34.2M, down 3.7% YoY; net income fell from $3.1M to $1.8M.
September 17, 2024, 7:59 PM ET other material materiality 0.75 positive item 8.01 item 9.01

GMRE signs 15-year triple-net lease with CHRISTUS Health at Beaumont facility after Steward bankruptcy rejection

New 15-year triple-net lease with CHRISTUS Health at Beaumont, TX facility for robotic surgery, orthopedics, emergency services.
August 6, 2024, 7:59 PM ET earnings materiality 0.65 negative item 2.02 item 9.01

Global Medical REIT Q2 net loss $3.1M; Steward risk; $30.8M acquisition closed

Net loss attributable to common stock of $3.1M ($0.05/diluted) vs income $11.8M ($0.18) Q2 2023; includes $3.4M loss on sale.
May 7, 2024, 7:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases

GMRE Q1 net income $0.8M, AFFO $0.23/share; Steward Health Care files Chapter 11

Net income $0.8M ($0.01/diluted share); FFO $14.9M ($0.21/unit); AFFO $16.5M ($0.23/unit).
February 27, 2024, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%

Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.
January 9, 2024, 6:59 PM ET other material materiality 0.65 neutral item 1.01 item 9.01 ◈ Material Agreements

Global Medical REIT registers $300M at-the-market equity program with forward sale option

Agreement with 14 agents and 9 forward sellers to sell up to $300M in common stock via ATM offerings.
November 6, 2023, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases

GMRE Q3 net income $3.1M ($0.05/diluted), FFO $0.22, revenue $35.5M; occupancy 96.7%

Net income attributable to common stockholders $3.1M ($0.05/diluted) vs $8.1M ($0.12) in prior-year Q3.
August 2, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT Q2 net income $11.8M; core FFO/AFFO down YoY; reduces leverage to 44.5%

Net income $11.8M ($0.18/diluted) vs $2.2M ($0.03) in prior year; includes $12.8M gain on sale.
May 3, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases

Global Medical REIT Q1 net income $0.7M ($0.01/shr); FFO $15.1M ($0.22/shr); revenue $36.2M (+13.7% YoY)

Net income $0.7M ($0.01 diluted EPS) vs $2.7M ($0.04) YoY; FFO $15.1M ($0.22/shr) vs $16.0M ($0.23); AFFO $16.0M ($0.23) vs $16.8M ($0.24).
February 28, 2023, 6:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT Q4 net income falls to $0.01 EPS; revenue up 19.6% to $36.3M

Q4 net income $0.4M ($0.01 diluted EPS) vs $3.8M ($0.06) YoY; AFFO flat at $0.24/share.

Executive changes

Appointed

Aaron Roseth

Chief Operating Officer

XRN · Chiron Real Estate Inc.

Effective: 2026-07-16
Filed: July 17, 2026, 4:40 PM ET

Aaron Roseth, age 51, was appointed as Chief Operating Officer of the Company and IAM.

Appointed

Robert Zeiller

Chief Development Officer and Head of Seniors Housing

XRN · Chiron Real Estate Inc.

Effective: 2026-07-16
Filed: July 17, 2026, 4:40 PM ET

Robert “Bobby” Zeiller, age 56, was appointed as Chief Development Officer and Head of Seniors Housing of Chiron Real Estate Inc. (the “Company”) and Inter-American Management LLC (“IAM”), and Aaron Roseth, age 51, was appointed as Chief Operating Officer of the Company and IAM.

Role change

Danica Holley

Chief Administrative Officer

XRN · Chiron Real Estate Inc.

Effective: 2026-07-16
Filed: July 17, 2026, 4:40 PM ET

Danica Holley transitioned from Chief Operating Officer to Chief Administrative Officer of the Company and IAM, effective July 16, 2026.

Appointed

Charles Fitzgerald

Director

XRN · Chiron Real Estate Inc.

Effective: 2026-05-20
Filed: May 20, 2026, 5:24 PM ET

On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.

Appointed

Mark O. Decker, Jr.

Chief Executive Officer and President

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Filed: June 23, 2025, 7:59 PM ET

Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025.

Role change

Jeffrey M. Busch

non-executive Chairman

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Successor: Mark O. Decker, Jr.
Filed: June 23, 2025, 7:59 PM ET

Mr. Busch was removed from his position as Chief Executive Officer and President of the Company, effective June 23, 2025. Mr. Busch will continue to serve on the board of directors of the Company (the “Board”) as non-executive Chairman.

Appointed

Mark O. Decker, Jr.

Director

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Filed: June 23, 2025, 7:59 PM ET

the Board also increased the size of the Board from seven directors to eight directors and appointed Mr. Decker as a director effective June 23, 2025

Departed

Dr. Roscoe Moore, Jr.

director

XRN · Chiron Real Estate Inc.

Filed: January 23, 2023, 6:59 PM ET

On January 19, 2023, Dr. Roscoe Moore, Jr. notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Board, effective as of the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”).

Earnings & guidance

2025-FY EPS reported -$0.91 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.62 · Most common event earnings

9 positive 7 negative 34 neutral

source · XRN on sec.gov